سعر فلوانكسول ديبو 40 مجم/2 مل حقن عضل 10 أمبولات 2026

Fluanxol Depot (H. Lundbeck A/S, Denmark; distributed in Egypt by Multipharma): a long-acting antipsychotic depot injection of flupentixol decanoate 20 mg/ml, presented as 2 ml ampoules (40 mg) for deep intramuscular injection, pack of 10 ampoules.

• Treatment of schizophrenia and other psychoses (restricted to patients stabilised on oral therapy).Population: Adultselectronic medicines compendium (emc), UK

• Very common: somnolence, akathisia, hyperkinesia, hypokinesia. Common: tremor, dystonia, dizziness, headache, insomnia, depression, nervousness, agitation, decreased libido, increased appetite and weight, tachycardia, palpitations, abnormal vision. Rare: thrombocytopenia, neutropenia, leukopenia, agranulocytosis, hyperprolactinaemia, hyperglycaemia, QT prolongation. Very rare: neuroleptic malignant syndrome. Tardive dyskinesia is uncommon to rare.International label, same formulation · electronic medicines compendium (emc), UK

• Hypersensitivity to flupentixol or any excipient; circulatory collapse; depressed level of consciousness from any cause (e.g. alcohol, barbiturate or opiate intoxication); coma. Not recommended for excitable or agitated patients.International label, same formulation · electronic medicines compendium (emc), UK

• Neuroleptic malignant syndrome (hyperthermia, muscle rigidity, fluctuating consciousness, autonomic instability) may occur; stop the neuroleptic and give supportive treatment. Symptoms may persist longer with depot forms.International label, same formulation · electronic medicines compendium (emc), UK
• May prolong the QT interval: use with caution in hypokalaemia, hypomagnesaemia, congenital predisposition, or cardiovascular disease (QT prolongation, bradycardia <50 bpm, recent myocardial infarction, uncompensated heart failure, arrhythmia).International label, same formulation · electronic medicines compendium (emc), UK
• Use with caution in liver disease, cardiac disease, severe respiratory disease, renal failure, epilepsy, Parkinson's disease, narrow-angle glaucoma, prostatic hypertrophy, thyroid disorders, myasthenia gravis and phaeochromocytoma.International label, same formulation · electronic medicines compendium (emc), UK

• Alcohol, barbiturates and other CNS depressantsFlupentixol enhances the response to alcohol and the effects of barbiturates and other CNS depressants.electronic medicines compendium (emc), UK
• QT-prolonging drugs (class Ia/III antiarrhythmics, thioridazine, erythromycin, some antihistamines, moxifloxacin, cisapride, lithium)Co-administration should be avoided because QT prolongation may be exacerbated.electronic medicines compendium (emc), UK
• LithiumCombined use of antipsychotics and lithium has been associated with an increased risk of neurotoxicity.electronic medicines compendium (emc), UK

• Safety in pregnancy has not been established; avoid use, especially in the first and last trimesters, unless the expected benefit outweighs the potential risk to the foetus. Animal studies showed reproductive toxicity.International label, same formulation · electronic medicines compendium (emc), UK
• Flupentixol is excreted into breast milk; if treatment is considered essential, nursing mothers should be advised to stop breast-feeding.International label, same formulation · electronic medicines compendium (emc), UK

• Flupentixol decanoate: Non-sedating thioxanthene antipsychotic whose primary action is dopamine blockade, with high affinity for D1 and D2 receptors. The decanoate ester is slowly released from the oil depot and hydrolysed to flupentixol; peak levels are reached about 7 days after injection.